Biogen Inc.
MX ˙ BMV ˙ US09062X1037
SecurityMX:BIIB / Biogen Inc.
InstitutionPlatform Technology Partners
Latest Disclosed Ownership1,201 shares
Latest Disclosed Value $ 220,179
Platform Technology Partners ownership in BIIB / Biogen Inc.

On April 27, 2026 - Platform Technology Partners filed a 13F-HR form disclosing ownership of 1,201 shares of Biogen Inc. (MX:BIIB) valued at $220,179 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 28, 2025 disclosing 0 shares of Biogen Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F BIOGEN COM 09062X103 1,201 1,201 220 0.0424
2025-01-28 2024-12-31 13F BIOGEN COM 09062X103 0 -1,403 -100.00 0 -100.00
2024-11-04 2024-09-30 13F BIOGEN COM 09062X103 1,403 -19 -1.34 272 -17.63 0.0855
2024-07-30 2024-06-30 13F BIOGEN COM 09062X103 1,422 133 10.32 330 4.44 0.1135
2024-02-13 2023-12-31 13F BIOGEN COM 09062X103 1,289 0 0.00 315 -4.83 0.1226
2023-11-08 2023-09-30 13F BIOGEN COM 09062X103 1,289 0 0.00 331 -8.06 0.1550
2023-07-12 2023-06-30 13F BIOGEN COM 09062X103 1,289 5 0.39 361 1.12 0.1698
2023-04-04 2023-03-31 13F BIOGEN COM 09062X103 1,284 -17 -1.31 357 -1.11 0.1763
2023-01-11 2022-12-31 13F BIOGEN COM 09062X103 1,301 -14 -1.06 360 2.56 0.1862
2022-10-24 2022-09-30 13F BIOGEN COM 09062X103 1,315 0 0.00 351 30.97 0.2000
2022-08-04 2022-06-30 13F BIOGEN COM 09062X103 1,315 0 0.00 268 -3.25 0.1463
2022-05-03 2022-03-31 13F BIOGEN COM 09062X103 1,315 -12 -0.90 277 -12.89 0.1332
2022-02-01 2021-12-31 13F BIOGEN COM 09062X103 1,327 -159 -10.70 318 -24.47 0.1397
2021-11-04 2021-09-30 13F BIOGEN COM 09062X103 1,486 0 0.00 421 -18.25 0.1909
2021-08-05 2021-06-30 13F BIOGEN COM 09062X103 1,486 290 24.25 515 75.77 0.2121
2021-02-09 2020-12-31 13F BIOGEN COM 09062X103 1,196 -19 -1.56 293 -15.07 0.1430
2020-11-30 2020-09-30 13F BIOGEN COM 09062X103 1,215 -66 -5.15 345 -14.81 0.2114
2020-11-30 2020-06-30 13F BIOGEN COM 09062X103 1,281 0 0.00 405 0.00 0.3301
2020-11-30 2020-03-31 13F BIOGEN COM 09062X103 1,281 -121 -8.63 405 -2.64 0.3688
2020-12-03 2019-12-31 13F BIOGEN COM 09062X103 1,402 1,402 416 0.3137
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.